openPR Logo

Press Releases from Antisoma plc (3 total)

direct/ Antisoma plc (UK) - Antisoma to present at Piper Jaffray Health Care Con …

20 June 2006, London, UK - Cancer drug developer Antisoma plc (LSE: ASM; USOTC: ATSMY) today announces that Glyn Edwards, its Chief Executive Officer, will present at Piper Jaffray´s first London Health Care Conference on Friday 23 June at 12.00 BST. Background on Antisoma Antisoma is a biopharmaceutical company that develops novel products for the treatment of cancer. Antisoma fills its development pipeline by acquiring promising new product candidates from internationally recognised

direct/ Antisoma plc (UK) - Antisoma to present at the Rodman and Renshaw confer …

10 May 2006, London, UK - Cancer drug developer Antisoma plc (LSE: ASM; USOTC: ATSMY) today announces that Glyn Edwards, its Chief Executive Officer, will present at the Rodman and Renshaw 3rd Annual Global Healthcare Conference on Tuesday 16 May at 13:00 CET in Monte Carlo. A webcast of the presentation will be available on Antisoma´s website www.antisoma.com . It is recommended that viewers log on 15 minutes early in

direct/ Antisoma plc (UK) - Antisoma to present at the BIO CEO conference

10 February 2006, London, UK - Cancer drug developer Antisoma plc (LSE: ASM; USOTC: ATSMY) today announces that its Director of Communications, Dr Daniel Elger, will participate in a panel session entitled "Revisiting Cytotoxics with New Molecules" at the BIO CEO and Investor Conference on Tuesday 14 February at 9.00am EST at the Waldorf Astoria Hotel in New York. Antisoma´s presentation will consider the potential to improve outcomes in patients

Go To Page:   1 2 3 4 5 6 7 8 9 10